Trial intelligence / Profile preview

Nolitong granules for frequent recurrent tension-type headache

CTR20140331Phase 2Completed

Sponsor
Beijing Plantai Pharmaceutical Technology Development
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Nuolitong in tension-type headache (TTH), sponsored by Beijing Plantai Pharmaceutical Technology Development. Started May 2014; status: completed.

02

Drugs

Nuolitong
03

Conditions

tension-type headache (TTH)

Beyond the preview

Go deeper on CTR20140331.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20140331.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call